Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Agenerase (amprenavir)

Health professionals are notified of important changes to the labeling for Agenerase Oral Solution. These changes highlight the potential risks, associated with the large amount of the excipient propylene glycol in Agenerase Oral Solution.

[May 1, 2000 - Letter - GlaxoWellcome]

-
-